CV Science

Pierre Buffet MD Dermatology Infectious diseases, PhD Microbial biochemistry

Course and current status

DIPLOMAS

1993 BsC  Biochemistry & Parasite Immunology Paris 6 University

1994 Master  Anti-microbial agents Paris 7 University

1995 MD Paris 5 University

1995 Specialization Dermatology Paris 5 University

1998 Specialization Dermatology & Emergency Paris 6 University

2000 PhD Microbial Biochemistry Paris 7 University

2003 Specialization Dermatology & Infection Paris 6 University            

2007 « Cours Pasteur » Medical Mycology Institut Pasteur

2007 Research Management Hability (HDR) 18/04/07Paris 6 University 

TRAINING PERIODS

1990 Resident, Medical Parasitology, Montpellier I University, France

1991-92 Visiting physician, Parasitology department, Medellin, Colombia

1993-94 Master student, Parasitology,  Paris 7 University

1995-96 Visiting MD, US Medical Research Unit - Brazil, Rio de Janeiro, Brésil

1997-00 PhD Biology of Host-Parasite Interactions, Institut Pasteur, Paris

1998 (summer) PhD student Laboratory of Parasitic Diseases, NIH, Bethesda 

 HOSPITAL-BASED & MANAGEMENT FUNCTIONS

1989 - 1995      Resident on duty Emergency room, Paris hospitals. (150 duties)

1997 - 2001      Dermatologist Dermatological emergency facility of Paris

1998 - 2001      Fellow, Infectious Diseases department,  Paris, France

2001 - 2004      Head, Medical & Clinical Research Center, Institut Pasteur, Paris

2004 - 2007      Head, Biomedical Research Team, Institut Pasteur, Paris

CURRENT POSITIONS

09 2007 - MCU-PH, Parasitology & Mycology, Salpêtrière Hospital, Paris, France

09 2007 - Group Leader "Erythrocytes Parasites Pathogenesis"

               UMR945 INSERM - UPMC Immunity & Infection

2009 - Member of TDR BL-10 (Elimination of Visceral Leishmaniasis), WHO

2010 - Adviser WHO Cutaneous leishmaniasis

Scientific summary

RESEARCH FIELDS & ACHIEVEMENTS

Malaria: Translational biomedical research on Malaria, Red Blood Cells and Splenic disorders. Clinical trials. Therapy of Severe Malaria. Parasite resistance to antimalarial drugs. Research on drugs blocking malaria transmission. Ex vivo and in vitro models of the human spleen. Innate processes controlling Plasmodium falciparum infection.

Leishmaniasis : Experimental chemotherapy, clinical and biomedical research Clinical trials  Pentamidine as an efficient therapy for New World Cutaneous leishmaniasis. Topical paromomycin as a new simple, affordable therapy for cutaneous leishmaniasis. Expert advice to physicians in collaboration with the French National Reference Center.